OBALON THERAPEUTICS INC·4

Mar 15, 6:15 PM ET

Plovanic William J. 4

4 · OBALON THERAPEUTICS INC · Filed Mar 15, 2018

Insider Transaction Report

Form 4
Period: 2018-03-13
Plovanic William J.
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2018-03-13$4.05/sh+9,588$38,8259,588 total(indirect: By Spouse)
  • Purchase

    Common Stock

    2018-03-13$4.05/sh+9,700$39,2769,700 total(indirect: By IRA)
  • Purchase

    Common Stock

    2018-03-14$4.04/sh+5,300$21,38715,000 total(indirect: By IRA)
  • Purchase

    Common Stock

    2018-03-14$4.04/sh+5,412$21,84315,000 total(indirect: By Spouse)
Holdings
  • Common Stock

    190,572
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $4.015 to $4.05, inclusive.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $3.99 to $4.05, inclusive.

Documents

1 file
  • 4
    marketforms-41497.xmlPrimary

    PRIMARY DOCUMENT